Sleeve-pex: A Randomized Trial to Reduce Reflux After Sleeve Gastrectomy

Recruiting now · Not applicable

Conditions studied: Gastroesophageal Reflux

In brief

The goal of this clinical trial is to test gastropexy as a measure to reduce reflux in morbidly obese patients being submitted to sleeve gastrectomy. The main questions it aims to answer are: Does gastropexy reduce reflux symptoms? Does gastropexy reduce objective evidence of reflux? Participants will be randomized to gastropexy or no gastropexy, and researchers will compare these groups to see if reflux (symptoms / objective evidence of) is different in the two groups.

Key facts

Study ID

NCT05704348

Run by

Helse Forde

People needed

550

Starts

2023-09-04

Expected to finish

2030-12-01

Last updated by the study team

2024-10-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients planned for bariatric surgery with primary LSG

You may not qualify if…

• Age below 18 yrs
• Use of ARM for other reasons than reflux
• Previous antireflux surgery
• Inability to comprehend and respon to patient related outcome (PRO) questionnaire

Where it is running

• Aleris Oslo — Oslo, Norway (enrolling)
• Volda sjukehus — Volda, Norway (enrolling)
• Voss sjukehus — Voss, Norway (enrolling)
• Helse Forde — Førde, Norway

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.